| Quantitation of mRNA using RT-PCR | 2006-04-11 |
| Analysis of Korean HBV wild type from asymptomatic HBV carrier | 2006-04-11 |
| Biochemical mechanism of platelet aggregation inhibition induced by magnasium | 2006-04-11 |
| Detection of mitochondrial tRNALys gene point mutation in myoclonic epilepsy with ragged-red fibers (MERRF) syndrome | 2006-04-11 |
| Application of single nucleotide primer extension for SNP research | 2006-04-11 |
| Overview of Clinical trials | 2006-04-11 |
| GCP and Ethical Aspects of Clinical Reseach | 2006-04-11 |
| Pharmacogenetics: A Principle fo the Personalized Pharmacotherapy | 2006-04-11 |
| Influence of P-glycoprotein modulators on cardiac uptake, metabolism, and effects of idarubicin | 2006-04-11 |
| Frequency of cytochrome P450 2C9 mutant alleles in a Korean population | 2006-04-11 |
| Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidol | 2006-04-11 |
| Clinical Pharmacogenomics: A Principle for tailored pharmacotherapy | 2006-04-11 |
| In vivo pharmacokinetics of pyribenzoxim in rats | 2006-04-11 |
| Simultaneous Determination of Furathiocarb and its Metabolites in Biological Tissues using High Performance Liquid Chromatography and Post-Column Derivatization | 2006-04-11 |
| Floss.Mutational Analysis and Reconstituted Expression of the Biosynthetic Genes Involved in the Formation of 3-Amino-5-hydroxybenzoic Acid, the Starter Unit of Rifamycin Biosynthesis in Amycolatopsis mediterranei S699. | 2006-04-11 |
| Microcystin-induced down-regulation of lymphocyte functions through reduced IL-2 mRNA stability. | 2006-04-11 |
| Association between TNF-α promoter polymorphism and Helicobacter pylori cagA subtype infection. | 2006-04-11 |
| The -238 tumor necrosis factor-α promoter polymorphism is associated with decreased susceptibility to cancers. | 2006-04-11 |
| Interaction of FACT, SSRP1, and the HMG Domain of SSRP1 with DNA Damaged by Anticancer Drug Cisplatin. | 2006-04-11 |
| Disposition kinetics of Ketoprofen into Synovial Fluid Following Systemic Administration : Population Pharmacokinetic Analysis | 2006-04-11 |
| Analysis of Prescriber's Responses on Clinical Pharmacokinetic Consultation of Therapeutic Dug Monitoring | 2006-04-11 |
| The GAM1 gene is not useful as a polymorphic marker in Korean isolates of Plasmodium vivax | 2006-04-11 |
| Analysis of polymorphic regions of Plasmodium vivax Duffy Binding Protein of Korean isolates | 2006-04-11 |
| Evaluation of LG malaria anti-PvTM for Diagnosis of Plasmodium vivax Malaria in the Republic of Korea | 2006-04-11 |
| Batetial Resistance Mechanism and Development of New Bacterial Agents | 2006-04-11 |
| Association between Tardive dyskinesia and soft neurological signs | 2006-04-11 |
| Cortisol and Prolactin Responses to Buspirone in Alcoholism | 2006-04-11 |
| Clinical Pharmacogenomics: A Principle for tailored pharmacotherapy | 2006-04-11 |
| Relationship of paroxetine disposition to metoprolol metabolic ratio and CYP2D6*10 genotype of Korean subjects | 2006-04-11 |
| Gas Chromatographic Analysis of Methiocarb and its Metabolites in Soil and Rice | 2006-04-11 |